Healthcare provider profile · identity verified

Joseph Olinger, M.D.

Family Practice · GURNEE, IL · NPI 1871548875

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	513	159
Amlodipine Besylate	Amlodipine Besylate	289	91
Losartan Potassium	Losartan Potassium	274	76
Lisinopril	Lisinopril	259	77
Metformin Hcl	Metformin Hcl	239	71
Hydrochlorothiazide	Hydrochlorothiazide	234	71
Levothyroxine Sodium	Levothyroxine Sodium	210	59
Omeprazole	Omeprazole	192	60
Metoprolol Succinate	Metoprolol Succinate	140	39
Simvastatin	Simvastatin	133	42
Rosuvastatin Calcium	Rosuvastatin Calcium	124	40
Meloxicam	Meloxicam	112	30
Albuterol Sulfate Hfa	Albuterol Sulfate	111	44
Famotidine	Famotidine	99	31
Gabapentin	Gabapentin	95	32
Pantoprazole Sodium	Pantoprazole Sodium	92	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	28
Tamsulosin Hcl	Tamsulosin Hcl	91	28
Pravastatin Sodium	Pravastatin Sodium	90	24
Diclofenac Sodium	Diclofenac Sodium	84	34
Carvedilol	Carvedilol	83	29
Eliquis	Apixaban	82	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	22
Metoprolol Tartrate	Metoprolol Tartrate	79	24
Ozempic	Semaglutide	78	17
Trazodone Hcl	Trazodone Hcl	78	21
Allopurinol	Allopurinol	71	19
Escitalopram Oxalate	Escitalopram Oxalate	66	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	64	16
Metformin Hcl Er	Metformin Hcl	64	21
Fluticasone Propionate	Fluticasone Propionate	61	28
Jardiance	Empagliflozin	61	17
Duloxetine Hcl	Duloxetine Hcl	54	18
Warfarin Sodium	Warfarin Sodium	53	12
Mounjaro	Tirzepatide	52	suppressed
Clopidogrel	Clopidogrel Bisulfate	51	18
Hydroxyzine Hcl	Hydroxyzine Hcl	51	21
Azelastine Hcl	Azelastine Hcl	50	27
Spironolactone	Spironolactone	50	18
Sertraline Hcl	Sertraline Hcl	47	12
Pregabalin	Pregabalin	46	11
Celecoxib	Celecoxib	43	19
Furosemide	Furosemide	42	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	15
Potassium Chloride	Potassium Chloride	42	14
Buspirone Hcl	Buspirone Hcl	41	14
Solifenacin Succinate	Solifenacin Succinate	41	11
Synthroid	Levothyroxine Sodium	41	11
Triamcinolone Acetonide	Triamcinolone Acetonide	41	32
Clonidine Hcl	Clonidine Hcl	40	13
Ezetimibe	Ezetimibe	40	15
Glimepiride	Glimepiride	38	14
Irbesartan	Irbesartan	38	11
Januvia	Sitagliptin Phosphate	38	12
Ketoconazole	Ketoconazole	37	17
Bupropion Xl	Bupropion Hcl	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	16
Ibandronate Sodium	Ibandronate Sodium	34	11
Benazepril Hcl	Benazepril Hcl	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	11
Baclofen	Baclofen	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	11
Naproxen	Naproxen	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Valsartan	Valsartan	28	suppressed
Lovastatin	Lovastatin	27	suppressed
Prednisone	Prednisone	27	20
Sildenafil Citrate	Sildenafil Citrate	27	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Glipizide	Glipizide	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Finasteride	Finasteride	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	13
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	18
Oxcarbazepine	Oxcarbazepine	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Linzess	Linaclotide	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Mupirocin	Mupirocin	16	15
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	15	suppressed
Cefdinir	Cefdinir	15	13
Colchicine	Colchicine	15	suppressed
Verapamil Sr	Verapamil Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error